A detailed history of Harvey Investment CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Harvey Investment CO LLC holds 80,116 shares of ABBV stock, worth $13.2 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
80,116
Previous 80,116 -0.0%
Holding current value
$13.2 Million
Previous $13.7 Million 15.14%
% of portfolio
1.79%
Previous 1.64%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $112,222 - $131,051
-725 Reduced 0.9%
80,116 $13.7 Million
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $60,891 - $69,380
-381 Reduced 0.47%
80,841 $14.7 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $738,774 - $832,033
-5,369 Reduced 6.2%
81,222 $12.6 Million
Q3 2023

Oct 18, 2023

SELL
$133.59 - $154.65 $292,562 - $338,683
-2,190 Reduced 2.47%
86,591 $12.9 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $647,973 - $806,361
-4,890 Reduced 5.22%
88,781 $12 Million
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $263,913 - $303,935
-1,825 Reduced 1.91%
93,671 $14.9 Million
Q4 2022

Jan 20, 2023

SELL
$138.31 - $165.87 $48,408 - $58,054
-350 Reduced 0.37%
95,496 $15.4 Million
Q3 2022

Oct 17, 2022

SELL
$134.21 - $153.93 $33,552 - $38,482
-250 Reduced 0.26%
95,846 $12.9 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $63,029 - $80,131
-458 Reduced 0.47%
96,096 $14.7 Million
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $150,061 - $186,183
-1,137 Reduced 1.16%
96,554 $15.7 Million
Q4 2020

Jan 21, 2021

SELL
$80.49 - $108.67 $6,439 - $8,693
-80 Reduced 0.08%
97,691 $10.5 Million
Q1 2020

Apr 21, 2020

SELL
$64.5 - $97.79 $167,700 - $254,254
-2,600 Reduced 2.59%
97,771 $7.45 Million
Q3 2019

Oct 21, 2019

SELL
$62.98 - $75.72 $176,344 - $212,016
-2,800 Reduced 2.71%
100,371 $7.6 Million
Q2 2019

Jul 16, 2019

SELL
$65.7 - $83.98 $45,990 - $58,786
-700 Reduced 0.67%
103,171 $7.5 Million
Q1 2019

Apr 11, 2019

SELL
$77.14 - $90.79 $522,777 - $615,283
-6,777 Reduced 6.12%
103,871 $8.37 Million
Q4 2018

Jan 31, 2019

BUY
$77.85 - $96.01 $21,798 - $26,882
280 Added 0.25%
110,648 $10.2 Million
Q3 2018

Oct 22, 2018

SELL
$88.91 - $98.84 $9.88 Million - $11 Million
-111,068 Closed
0 $0
Q2 2018

Jul 24, 2018

SELL
$89.78 - $106.23 $43,363 - $51,309
-483 Reduced 0.43%
111,068 $10.3 Million
Q1 2018

Apr 23, 2018

BUY
$92.01 - $123.21 $56,402 - $75,527
613 Added 0.55%
111,551 $10.6 Million
Q3 2017

Oct 18, 2017

BUY
$69.85 - $89.22 $7.75 Million - $9.9 Million
110,938
110,938 $9.86 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Harvey Investment CO LLC Portfolio

Follow Harvey Investment CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Investment CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Investment CO LLC with notifications on news.